Myriad Genetics Announces Third Quarter Fiscal 2006 Financial Results Conference Call; Tuesday, May 2, 2006 at 10:00 a.m. ET

SALT LAKE CITY, April 18, 2006–Myriad Genetics, Inc. (Nasdaq: MYGN) (www.myriad.com) has arranged a conference call with the management team to provide a company update. Peter Meldrum, President and Chief Executive Officer will host the call along with Jay Moyes, Chief Financial Officer, Gregory Critchfield, M.D., President of Myriad Genetic Laboratories, Inc., Adrian Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc., and Jerry Lanchbury, Ph.D., Executive Vice President of Research.

(Please dial in approximately 10 minutes before the call is scheduled to begin)

A press release will be issued at 6:30 a.m. ET on May 2, 2006.

Replay of the call will be available from two hours after the call through May 9 by dialing 800-642-1687 or 706-645-9291, and entering conference ID number 8218738.

A live audio Webcast will be available at: www.myriad.com

This call is being webcast by Thomson/CCBN and is also being distributed though the Thomson/StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.fulldisclosure.com, Thomson/CCBN's individual investor portal. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).